Dr. Rick Baehner Discusses a Test to Help Personalize Advanced Cancer Care

Patients with advanced cancers can now receive a personalized test that provides their doctors with key information they need to make important decisions about therapy, based on the patient’s cancer. The OncoExTra™ test, launched by Exact Sciences, is a new, comprehensive genomic test that evaluates the patient’s tumor – using RNA and DNA – and then identifies appropriate and available cutting-edge immunotherapies, as well as options for clinical trials for investigational therapies. The test is now available for patients with all solid tumors that are stage 3 or 4, and is covered by Medicare.

DocWire News spoke with Dr. Rick Baehner, Chief Medical Officer of Precision Oncology at Exact Sciences, about how the Company is helping physicians to make more informed decisions about cancer treatment.